Press Release
news head

March 20, 2016

Nucleix Introduced Bladder EpiCheck in the European Association of Urology (EAU) Annual Meeting

Nucleix presented Bladder EpiCheck during the annual meeting of the European Association of Urology (EAU), to expose more than 12,000 urology professionals to the upcoming launch of Bladder EpiCheck in the EU. The meeting took place in Munich during March

read more >

Article
news head

June 16, 2014

Cancer screening company Nucleix raises $5m

Orbimed Israel and Zohar Zisapel participated in the financing round. Nucleix, which is developing a test for early detection of bladder cancer, has raised more than $5 million in an investment round led by venture capital firm OrbiMed Advisors LLC.

read more >